Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 16;108(8):2178–2191. doi: 10.3324/haematol.2022.281510

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2023 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 3. — m7-ATLPI segregates patients with favorable prognosis from among low- or intermediate-risk patients defined by ATL prognostic models based on clinical parameters. (A) Kaplan-Meier overall survival (OS) curves stratified by the m7-adult T-cell leukemia/lymphoma prognostic index (m7-ATLPI) for patients in the entire cohort (training and validation cohorts) who were classified as low risk or intermediate risk by the ATL-PI. (B) Kaplan-Meier OS curves stratified by the m7-ATLPI for patients in the entire cohort who were classified as moderate risk by the Japan Clinical Oncology Group prognostic index. (C) Kaplan-Meier OS curves stratified by the m7-ATLPI for patients in the entire cohort who were classified as low risk or intermediate risk by the modified ATL-PI. Numbers in parentheses show the number of patients with events/number of patients per cohort.